Related Experiment Videos

Infusion of clotting factor concentrates in haemophilia

British Journal of Haematology

|August 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Long-term surveillance for human anti-murine antibodies of a group of haemophiliacs treated only with immunoaffinity-purified FVIII concentrates.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Haemophilia : the official journal of the World Federation of Hemophilia·2012

Potency and mass of factor VIII in FVIII products.

Haemophilia : the official journal of the World Federation of Hemophilia·2008

The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2006

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate): a prospective pharmacovigilance study.

Haemophilia : the official journal of the World Federation of Hemophilia·2004

See all related articles